Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GSK plc (GSK) vs Stellantis N.V. Common Shares (STLA) Price & Performance

Stellantis N.V. Common SharesTrade

Price performance (Past 24H)

Key statistics

GSK plc vs Stellantis N.V. Common Shares — how do they compare? GSK plc trades at $48.84 (market cap $96.45B), while Stellantis N.V. Common Shares trades at $4.26 (market cap $16.20B). The key difference: GSK plc is far larger — about 6× Stellantis N.V. Common Shares's market cap, and GSK plc pays a 3.79% dividend while Stellantis N.V. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold GSK plc for 93 Days and Stellantis N.V. Common Shares for 0 Days on average.

GSKSTLA
Market Cap
$96.45B$16.20B
Volume
7,087,45730,607,418
Sector
HealthConsumer Cyclical
52-Week High
$61.18$12.12
52-Week Low
$43.24$4.27
Typical Hold Time
93 Days0 Days
Enterprise Value
$116.51B$35.94B
Dividend Yield
3.79%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GSK plc

GSK trades at $46.27, down 1.39% today, with a bearish technical signal from moving averages. The company shows strong profitability with 72.73% gross margins and 14.52% net income margin, supported by three consecutive quarterly earnings beats. Recent developments include a $750M cancer therapy acquisition and strategic focus on oncology growth targeting £40B in sales. Cash flow trends show consistent operational strength with $7.7B from operations in 2025.

GSK presents a mixed outlook with strong fundamentals offset by technical weakness. The stock offers value with a 14.84 P/E ratio and dividend yield, but faces headwinds from HIV patent expirations and bearish technical indicators. Analyst consensus leans cautious with 55% hold ratings, suggesting patience may be warranted despite the company's solid operational performance.

Stellantis N.V. Common Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GSK
100% Buy0% Sell
Avg holding period · 93 Days
STLA
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About GSK plc

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Read more on GSK →

About Stellantis N.V. Common Shares

Stellantis N.V. is a multinational automaker formed from the 2021 merger of Fiat Chrysler Automobiles and PSA Group, manufacturing vehicles under brands including Jeep, Ram, Chrysler, Dodge, Fiat, Peugeot, and Citroën.

Read more on STLA →